Hoots In the News
Just as in other fields, scientific diversity has been and continues to be critical for the success of HLB research.
This editorial examines the diversity of topics and mechanisms in the NHLBI portfolio.
Although it is a relatively new therapy, bone marrow transplantation has become a routine treatment for patients with a variety of genetic disorders and blood diseases. However, for patients who don't have a matching related donor, finding a match can be a long, frustrating, and ultimately unsuccessful process. This is especially true for people from ethnic and racial minorities.
A treatment that prevents strokes in children with sickle cell anemia was announced today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.